As I said above: You are downplaying a very real and sad state of affairs with “but money must be made”. Sadly that is the state of things, but you put it as if this is as it should be.

You are excusing predatory business practices and growing income divide. You are apparently okay with businesses having so much political power they can dictate laws. Regulations and actual sanctions, anti monopoly laws and corruption, unions and raised minimum wages would severely lower the amount of money for investers across the board and the world would be a better place for it.

You present as something without any empathy. Someone laments the state of things and you say: good way to make a profit and draw investors! Tone deaf.

The people who did the work? Like the researchers at Novo that mainly just get salary? Let them have their salary, patents and scientific recognition. That is their credit.

Indeed Novo has built upon a lot of research and most of that is publicly funded. The price of the drug of course should recompense the organization for costs in research, trials and approval.

Still it is strange that costs to the consumer are 9 times higher on the US market than in Europe.

Also, it’s strange that capitalisation is so free in making money that high prices are required to attract capital for helping and healing people. Human lives are worth less than profits. Gross amounts of money are making their way to sociopaths. You are downplaying a very real and sad state of affairs with “but money must be made”. Sadly that is the state of things, but you put it as if this is as it should be.

Insulin was named as an example which you gloss over, where research wasn’t needed and production could be optimized for larger profits, but prices were raised to the point of people cutting back on their intake. This has caused bodily damage, loss of eyesight, loss of life. This wasn’t to the benefit of the working people, and to the deficit of patients.

I think people are starting to become a lot more aware of what advantages are given up by changing the status quo. Not just w.r.t. China, but with a lot of American products, such as cloud, payment providers, operating systems, document processors etc.

Still, this can be abused in the short term on the stock market, so I doubt things will change much.

It talks about DUV (deep ultra violet), last generation, not EUV (extreme ultra violet). So China is now a competitor on part of ASML’s market where they held about 95% market share, not on their 100% top of the line models that can go even more detailed.

Since ASML DUV line has been around longer they worked on increasing stability and performance, so likely they won’t be outperformed globally, yet. But China has extra incentive not to buy Dutch since they won’t sell them EUV. This will have a noticable effect on their revenue, but it’s speculation as to how much revenue they will loose unless China mandates their own product.

Also, ASML is increasing DUV capabilities beyond the laser input size + lenses with a bubble of water which changes the refractory index which lays on top of the wafer, no idea if that is in the Chinese products. If it isn’t we are basically talking about the 4th gen machine. It’s DUV, DUV + water, EUV (needing mirrors since lenses now absorb this light), EUV with increased height requirements for the clean rooms).

Sounds more like the fee they directly use for lobbying to reduce oversight on ISPs.

Using existing LLMs functionality with fewer steps. You can have a chatbot in the side bar, no doubt keeping track of all your browsing habits to better assist you which incidentally builds a very valuable profile of the user companies would love to buy. Summarizing large texts so AI generated slop and search algorithm filler content can be filtered out more efficiently vs a decent chance at introducing errors. Rewording text so you can make it more simple, translated, adhering to your world view. All of this with minimal clicks, automatically done if possible.